| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.57▼ | 0.58▼ | 0.58▼ | 0.59▼ | 0.58▼ |
| MA10 | 0.58▼ | 0.59▼ | 0.59▼ | 0.61▼ | 0.59▼ |
| MA20 | 0.60▼ | 0.60▼ | 0.60▼ | 0.59▼ | 0.61▼ |
| MA50 | 0.61▼ | 0.63▼ | 0.62▼ | 0.59▼ | 0.67▼ |
| MA100 | 0.63▼ | 0.61▼ | 0.60▼ | 0.61▼ | 0.77▼ |
| MA200 | 0.63▼ | 0.60▼ | 0.60▼ | 0.64▼ | 0.93▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.004▼ | -0.004▼ | -0.003▼ | 0.003▲ |
| RSI | 34.951▼ | 35.755▼ | 35.998▼ | 43.554▼ | 41.440▼ |
| STOCH | 22.780 | 18.526▼ | 18.526▼ | 29.654 | 22.648 |
| WILL %R | -93.305▼ | -93.305▼ | -93.305▼ | -94.818▼ | -93.125▼ |
| CCI | -94.421 | -120.441▼ | -121.196▼ | -92.633 | -34.795 |
|
Thursday, November 06, 2025 06:38 AM
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema ...
|
|
Thursday, November 06, 2025 05:16 AM
Findings highlight negative psychosocial impact of HAE attacks and resulting ED/hospital visits on pediatric patients and their caregivers – – ORLADEYO oral granules demonstrated early and sustained ...
|
|
Wednesday, November 05, 2025 09:18 PM
Jazz Pharmaceuticals PLC (JAZZ) reports a robust quarter with record revenue, strategic FDA approvals, and a strengthened pipeline, despite facing competitive challenges.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/25 | 0.5937 | 0.5941 | 0.5651 | 0.5657 | 81,510 |
| 05/11/25 | 0.596 | 0.5998 | 0.571 | 0.5941 | 48,576 |
| 04/11/25 | 0.615 | 0.646 | 0.56 | 0.582 | 586,100 |
| 03/11/25 | 0.611 | 0.627 | 0.60 | 0.624 | 232,100 |
| 31/10/25 | 0.60 | 0.62 | 0.59 | 0.603 | 49,400 |
| 30/10/25 | 0.628 | 0.628 | 0.583 | 0.59 | 104,100 |
| 29/10/25 | 0.63 | 0.67 | 0.63 | 0.638 | 311,400 |
| 28/10/25 | 0.62 | 0.667 | 0.62 | 0.651 | 257,200 |
| 27/10/25 | 0.615 | 0.65 | 0.581 | 0.637 | 211,300 |
| 24/10/25 | 0.64 | 0.65 | 0.616 | 0.62 | 306,500 |
|
|
||||
|
|
||||
|
|